Ticovac Global Market Report 2025

Ticovac Global Market Report 2025 ) – By Formulation (Inactivated Vaccines, Live Attenuated Vaccines), By Indication (Tick-Borne Encephalitis, Japanese Encephalitis, Rabies Encephalitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Name: Ticovac Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Ticovac Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Ticovac Market Definition

TicoVac is a vaccine used to protect against tick-borne encephalitis (TBE), a viral disease transmitted primarily through tick bites or, less commonly, by consuming unpasteurized dairy products from infected animals. TBE affects the central nervous system and can lead to severe neurological complications, including meningitis and encephalitis. TicoVac works by stimulating the immune system to recognize and fight the tick-borne encephalitis virus (TBEV) if exposed in the future.

The main types of ticovac formulations are inactivated vaccines and live attenuated vaccines. Tick-borne encephalitis is a viral infection transmitted through the bite of infected ticks, affecting the central nervous system and potentially leading to severe neurological complications. It is used for tick-borne encephalitis, Japanese encephalitis, and rabies encephalitis and is distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Ticovac Market Segmentation

The ticovacmarket covered in this report is segmented –

1) By Formulation: Inactivated Vaccines, Live Attenuated Vaccines

2) By Indication: Tick-Borne Encephalitis, Japanese Encephalitis, Rabies Encephalitis

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Ticovac Market Size and growth rate 2025 to 2029: Graph

Ticovac Market Size 2025 And Growth Rate

The ticovac market size has grown strongly in recent years. It will grow from $4,010 million in 2024 to $4,310 million in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growing awareness, increase in travel to endemic areas, rising veterinary concerns, rising geriatric population, rising military and defense vaccinations.

Ticovac Market Growth Forecast

The ticovac market size is expected to see strong growth in the next few years. It will grow to $5,700 million in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing in outdoor workers, increasing healthcare expenditure, increasing focus on regional disease control, rising in health insurance coverage, rising incidence of tick-borne encephalitis (tbe) cases. Major trends in the forecast period include technological advancements in vaccine production, introduction of new tbe vaccines, collaborations between governments and pharmaceutical companies, advances in genetic research, advances in monitoring and post-vaccination care.

Book your 30 minutes free consultation with our research experts

Ticovac Market Driver: Rising Prevalence Of Tick-Borne Diseases Driving Growth In The Ticovac Market

The rising prevalence of tick-borne diseases is expected to drive the growth of the ticovac market going forward. Tick-borne diseases are illnesses transmitted to humans through the bite of infected ticks, caused by bacteria, viruses, or parasites. Tick-borne diseases are rising due to climate change, expanding tick habitats, increased human exposure, and better diagnostics. Ticovac is required for tick-borne diseases as it provides active immunization against tick-borne encephalitis (TBE), a potentially severe viral infection transmitted through tick bites. For instance, in February 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the overall incidence of Lyme disease was 18.9 cases per 100,000 population, with a rate 68.8% higher than in previous years. Among high-incidence jurisdictions, the median rate was 58% higher at 68.3 cases per 100,000, while for children aged 5–9 years, the incidence was 16.5 cases per 100,000, reflecting an 11.5% increase. Therefore, the rising prevalence of tick-borne diseases is driving the growth of the ticovac market.

Ticovac Market Driver: Rising Research And Development Activities Fuel Growth In The Ticovac Market

The increasing research and development activities are expected to drive the growth of the ticovac market going forward. Research and development (R&D) activities involve the systematic investigation and innovation aimed at creating new products, improving existing ones, or developing new technologies and solutions through scientific and technical research. Research and development activities are rising due to the growing demand for innovation, technological advancements, and the need to address emerging global challenges in various industries. Research and development activities positively impact TicoVac by driving advancements in vaccine formulation, enhancing efficacy, and ensuring its continued ability to address emerging strains of tick-borne encephalitis. For instance, in July 2024, according to the Department of Health and Social Care, a UK-based government department, the business enterprise sector spent $11.3 billion (£9.0 billion) on pharmaceutical research and development in 2022, representing 0.36% of the UK's GDP. Pharmaceutical R&D made up 18% of all business-conducted R&D in the UK that year, the highest share among all product sectors. Therefore, the increasing research and development activities are driving the growth of the ticovac market.

Global Ticovac Market Major Players

Major companies operating in the ticovac market include Pfizer Inc.

Global Ticovac Market Trend: Suspension Formulation Boosts Competitive Edge In The Ticovac Market

The key trend in the ticovac market is focusing on innovative formulations such as suspension liquid to gain a competitive edge in the industry. Suspension liquid is a vaccine formulation for the prevention of tick-borne encephalitis, available for intramuscular injection. It comes in a 0.5 mL dose and is designed for both adult and pediatric use. For instance, in September 2024, Pfizer Inc., a US-based pharmaceutical manufacturer, launched Ticovac, a vaccine aimed at preventing tick-borne encephalitis (TBE), a viral infection that affects the brain and spinal cord. The vaccine is the first of its kind in Japan, offering protection against the disease in regions where it is prevalent. The vaccine is available in two versions, one for adults and one for children, both as a 0.5 mL intramuscular injection.

Regional Outlook For The Global Ticovac Market

Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ticovac market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ticovac Market?

The ticovac market consists of sales of pediatric vaccines, cardiovascular and metabolic products, anti-infective medications and rare disease medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ticovac Industry?

The ticovac market research report is one of a series of new reports from The Business Research Company that provides ticovac market statistics, including ticovac industry global market size, regional shares, competitors with a ticovac market share, detailed ticovac market segments, market trends and opportunities, and any further data you may need to thrive in the ticovac industry. This ticovac market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ticovac Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 7.3% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Formulation: Inactivated Vaccines, Live Attenuated Vaccines 2) By Indication: Tick-Borne Encephalitis, Japanese Encephalitis, Rabies Encephalitis 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Pfizer Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Ticovac Market Characteristics

3. Ticovac Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Ticovac Market Trends And Strategies

5. Ticovac Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Ticovac Growth Analysis And Strategic Analysis Framework

6.1. Global Ticovac PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Ticovac Market Growth Rate Analysis

6.4. Global Ticovac Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Ticovac Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Ticovac Total Addressable Market (TAM)

7. Global Ticovac Market Pricing Analysis & Forecasts

8. Ticovac Market Segmentation

8.1. Global Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Vaccines

Live Attenuated Vaccines

8.2. Global Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tick-Borne Encephalitis

Japanese Encephalitis

Rabies Encephalitis

8.3. Global Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

9. Global Ticovac Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Ticovac Market Regional And Country Analysis

10.1. Global Ticovac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Ticovac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Ticovac Market

11.1. Asia-Pacific Ticovac Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Ticovac Market

12.1. China Ticovac Market Overview

12.2. China Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Ticovac Market

13.1. India Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Ticovac Market

14.1. Japan Ticovac Market Overview

14.2. Japan Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Ticovac Market

15.1. Australia Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Ticovac Market

16.1. South Korea Ticovac Market Overview

16.2. South Korea Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Ticovac Market

17.1. Western Europe Ticovac Market Overview

17.2. Western Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Ticovac Market

18.1. UK Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Ticovac Market

19.1. Germany Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Ticovac Market

20.1. France Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ticovac Market

21.1. Eastern Europe Ticovac Market Overview

21.2. Eastern Europe Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Ticovac Market

22.1. North America Ticovac Market Overview

22.2. North America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Ticovac Market

23.1. USA Ticovac Market Overview

23.2. USA Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Ticovac Market

24.1. Canada Ticovac Market Overview

24.2. Canada Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Ticovac Market

25.1. South America Ticovac Market Overview

25.2. South America Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Ticovac Market

26.1. Middle East Ticovac Market Overview

26.2. Middle East Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Ticovac Market

27.1. Africa Ticovac Market Overview

27.2. Africa Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Ticovac Market Competitive Landscape And Company Profiles

28.1. Ticovac Market Competitive Landscape

28.2. Ticovac Market Company Profiles

28.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Ticovac Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Ticovac Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Ticovac Market

32. Recent Developments In The Ticovac Market

33. Ticovac Market High Potential Countries, Segments and Strategies

33.1 Ticovac Market In 2029 - Countries Offering Most New Opportunities

33.2 Ticovac Market In 2029 - Segments Offering Most New Opportunities

33.3 Ticovac Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Ticovac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Ticovac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Pfizer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Ticovac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Ticovac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Ticovac Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Ticovac Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Ticovac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Pfizer Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the protein purification and isolation market research report 2022 with industry size, share, segments and market growth

Prenatal Testing & Newborn Screening Global Market Report 2025 – By Diagnostic Type (Non-Invasive, Invasive), By Technology (Screening Technology, Diagnostic Technology), By End user (Hospitals, Diagnostic centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Prenatal And Newborn Genetic Testing Global Market Report 2025 – By Product Type (Consumables, Instruments), By Screening (Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings), By Disease (Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), By End User (Hospital, Maternity And Specialty Clinics, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pertussis Vaccine Global Market Report 2025 – By Product Type (DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine), By Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), By Application (Children, Adults, Infants), By End-User (Vaccination Centers, Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

H1N1 Vaccine Global Market Report 2025 – By Product Type( Inactivated Vaccine, Live Attenuated Vaccine ), By Route Of Administration( Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination ), By End Users( Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Adult Vaccines Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application (Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis), By End Users (Healthcare Firms, Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Therapeutic BCG Vaccines Global Market Report 2025 – By Type (Therapy BCG, Immune BCG), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Conjugate Vaccine Global Market Report 2025 – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meningococcal, Typhoid), By Patient (Pediatric, Adults), By End-User (Hospitals, Clinics, Homecare Settings, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Ticovac market?

How will the Ticovac market drivers and restraints affect the market dynamics? What forces will shape the Ticovac industry going forward?

The Ticovac market major growth driver - Rising Prevalence Of Tick-Borne Diseases Driving Growth In The Ticovac Market. For further insights on the Ticovac market, request a sample here

What is the forecast market size or the forecast market value of the Ticovac market?

The Ticovac market size has grown strongly in recent years. The ticovac market size has grown strongly in recent years. It will grow from $4,010 million in 2024 to $4,310 million in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growing awareness, increase in travel to endemic areas, rising veterinary concerns, rising geriatric population, rising military and defense vaccinations. The ticovac market size is expected to see strong growth in the next few years. It will grow to $5,700 million in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing in outdoor workers, increasing healthcare expenditure, increasing focus on regional disease control, rising in health insurance coverage, rising incidence of tick-borne encephalitis (tbe) cases. Major trends in the forecast period include technological advancements in vaccine production, introduction of new tbe vaccines, collaborations between governments and pharmaceutical companies, advances in genetic research, advances in monitoring and post-vaccination care. For further insights on the Ticovac market, request a sample here

How is the Ticovac market segmented?

The ticovacmarket covered in this report is segmented –
1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines
2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies For further insights on the Ticovac market, request a sample here

Which region has the largest share of the Ticovac market? What are the other regions covered in the report?

Who are the major players in the Ticovac market?

Major companies operating in the ticovac market include Pfizer Inc. . For further insights on the Ticovac market, request a sample here.

What are the key trends in the Ticovac market?

Major trends in the Ticovac market include Suspension Formulation Boosts Competitive Edge In The Ticovac Market. For further insights on the Ticovac market, request a sample here.

What are the major opportunities in the Ticovac market? What are the strategies for the Ticovac market?

For detailed insights on the major opportunities and strategies in the Ticovac market, request a sample here.

How does the Ticovac market relate to the overall economy and other similar markets?

For detailed insights on Ticovac's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Ticovac industry?

For detailed insights on the mergers and acquisitions in the Ticovac industry, request a sample here.

What are the key dynamics influencing the Ticovac market growth? SWOT analysis of the Ticovac market.

For detailed insights on the key dynamics influencing the Ticovac market growth and SWOT analysis of the Ticovac industry, request a sample here.